Literature DB >> 18521561

[Uro-oncological research from the laboratory and clinical practice].

D Engeler1, B Ludewig, H-P Schmid.   

Abstract

This report presents current work and results of projects in the uro-oncological field from the Cantonal Hospital of St. Gallen. The first part deals with dendritic cell-based immunotherapy of hormone refractory prostate cancer. In the second part, some recent results of clinical and laboratory work for non-muscle invasive bladder cancer are highlighted.

Entities:  

Mesh：

Year:  2008        PMID： 18521561     DOI： 10.1007/s00120-008-1779-1

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


  5 in total

1.  Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer.

Authors:  Eric J Small; Paul F Schellhammer; Celestia S Higano; Charles H Redfern; John J Nemunaitis; Frank H Valone; Suleman S Verjee; Lori A Jones; Robert M Hershberg
Journal:  J Clin Oncol       Date:  2006-07-01       Impact factor: 44.544

2.  Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma.

Authors:  Ying Waeckerle-Men; Edith Uetz-von Allmen; Markus Fopp; Roger von Moos; Christel Böhme; Hans-Peter Schmid; Daniel Ackermann; Thomas Cerny; Burkhard Ludewig; Marcus Groettrup; Silke Gillessen
Journal:  Cancer Immunol Immunother       Date:  2006-04-13       Impact factor: 6.968

3.  [Adaptive immunotherapy of the advanced prostate cancer - cancer testis antigen (CTA) as possible target antigens].

Authors:  L Prikler; E Scandella; Y Men; D S Engeler; P-A Diener; S Gillessen; B Ludewig; H-P Schmid
Journal:  Aktuelle Urol       Date:  2004-08       Impact factor: 0.658

4.  Feasibility of early intravesical instillation chemotherapy after transurethral resection of the bladder: a prospective evaluation in a consecutive series of 210 cases.

Authors:  Daniel S Engeler; Stephen Wyler; Michael Neyer; Christian Hobi; Jurg Müller; Hans-Peter Schmid
Journal:  Scand J Urol Nephrol       Date:  2008

5.  A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials.

Authors:  Richard J Sylvester; Willem Oosterlinck; Adrian P M van der Meijden
Journal:  J Urol       Date:  2004-06       Impact factor: 7.450
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.